Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells

BACKGROUND: Calciprotein particles (CPPs), colloidal mineral-protein nanoparticles, have emerged as potential mediators of phosphate toxicity in dialysis patients, with putative links to vascular calcification, endothelial dysfunction and inflammation. We hypothesized that phosphate binder therapy w...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiem, Ursula, Hewitson, Tim D, Toussaint, Nigel D, Holt, Stephen G, Haller, Maria C, Pasch, Andreas, Cejka, Daniel, Smith, Edward R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157755/
https://www.ncbi.nlm.nih.gov/pubmed/36107466
http://dx.doi.org/10.1093/ndt/gfac271